HUNAN FANGSHENG PHARMACEUTICAL CO.,LTD

HUNAN
Company Profile
HUNAN

Fangsheng is a high-quality, comprehensive, research-based pharmaceutical health industry group integrating the pharmaceutical industry, medical services, health care & nursing home, which owns more than 10 subsidiaries. Fangsheng was successfully listed in Shanghai Stock Exchange in 5th, Dec, 2014 with the stock code 603998.
Fangsheng takes "Your health, Fangsheng's pursuit" as its corporate mission. Fangsheng has been exploring, trying and developing in various fields of great health for over 10 years, dedicating to serving for human health.
Regarding "new drug R & D capability" as the core competitive advantage of the enterprise, Fangsheng integrates the advantages of the world's top new drug R & D resources, builds a high-level R & D team, and confirms a concept of keeping pace with traditional Chinese medicine, chemical medicine and biological medicine, and develops the product R&D strategy characterized by imitation,improvement and innovation of chemical compound as well as internationalization.
Possessing multiple production bases such as in Changsha, Hainan, Liaoning, Yunnan, Fangsheng sets up an integrated product control and assurance system by strictly producing in accordance with the new version of GMP and the excellent performance system.
In the future, Fang Sheng will continue to take the pharmaceutical industry as the main body, strengthen the core competitive advantage of new drug research and development, leverage the  industry development with the help of capital, and finally realize the strategic layout of "one body, two wings" of pharmaceutical industry, medical service and pension care service, building a high-quality, comprehensive, research-based type of health industry aircraft carrier and realizing Fang Sheng's dream and health dream!

more >

Year of Establishment: 2002

Total Assets(USD):

Total Number of Staff:

Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: Core Competitive Advantage--R&D of New Drugs "1 +N" model of new drug R&D system High-level new drug R&D platform Top talent R&D team High investment into R & D Plentiful R&D achievement 8% sales revenue invested in R&D every year R&D team accounting for 10% of total employees 500 million RMB R&D fund (cooperating with changsha municipal government and High-tech zone)

Patents and Copyrights: 9 items of China Invention Patent 116 items of Drug Production License 17 pieces of New Drug Certificate 2 items of National Major New Drug Innovation and Research Specific Project

Send your message to this supplier
  • From:
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service